A retrospective analysis of combination therapy with GLP-1 receptor agonists and SGLT2 inhibitors versus SGLT2 inhibitor monotherapy in patients with MASLD.

Nat Commun · 2025 · PMC12343782 · PMID 40796776

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

approaches statistical significanceno p-value reported

Moreover, the relatively wide confidence interval, which approaches statistical significance, suggests that a larger sample size or longer follow-up may be necessary to definitively assess the cardiovascular impact of combination therapy in MASLD patients.

also in 141 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.